A Phase 3, Randomized, Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Efficacy And Safety Of Celecoxib (Celebrex) And Indomethacin In The Treatment Of Moderate To Severe Acute Gouty Arthritis.

Trial Profile

A Phase 3, Randomized, Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Efficacy And Safety Of Celecoxib (Celebrex) And Indomethacin In The Treatment Of Moderate To Severe Acute Gouty Arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Oct 2012

At a glance

  • Drugs Celecoxib (Primary) ; Indometacin
  • Indications Gouty arthritis; Musculoskeletal pain
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Aug 2012 Results published in The Journal of Rheumatology.
    • 08 Nov 2010 Results presented at the 74th Annual Scientific Meeting of the American College of Rheumatology and the 45th Annual Meeting of the Association of Rheumatology Health Professionals.
    • 27 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top